About This Event
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN), a company developing treatments for severe neurodegenerative diseases, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, NeuroSense’s CEO, Alon Ben-Noon, rings the Opening Bell.